nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP2C8—Raloxifene—osteoporosis	0.0924	0.127	CbGbCtD
Halofantrine—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0893	0.123	CbGbCtD
Halofantrine—CYP2C8—Cholecalciferol—osteoporosis	0.0714	0.0983	CbGbCtD
Halofantrine—CYP3A5—Estradiol—osteoporosis	0.0598	0.0824	CbGbCtD
Halofantrine—CYP2C8—Estradiol—osteoporosis	0.0575	0.0793	CbGbCtD
Halofantrine—CYP3A4—Estropipate—osteoporosis	0.0562	0.0774	CbGbCtD
Halofantrine—CYP3A4—Calcitriol—osteoporosis	0.0562	0.0774	CbGbCtD
Halofantrine—CYP2D6—Cholecalciferol—osteoporosis	0.0455	0.0627	CbGbCtD
Halofantrine—CYP3A4—Ergocalciferol—osteoporosis	0.0449	0.0619	CbGbCtD
Halofantrine—CYP3A4—Raloxifene—osteoporosis	0.0375	0.0516	CbGbCtD
Halofantrine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0362	0.0499	CbGbCtD
Halofantrine—CYP3A4—Cholecalciferol—osteoporosis	0.0289	0.0399	CbGbCtD
Halofantrine—CYP3A4—Conjugated Estrogens—osteoporosis	0.0266	0.0366	CbGbCtD
Halofantrine—CYP3A4—Estradiol—osteoporosis	0.0233	0.0321	CbGbCtD
Halofantrine—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000792	0.00289	CcSEcCtD
Halofantrine—Paraesthesia—Estropipate—osteoporosis	0.00078	0.00284	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Alendronate—osteoporosis	0.00078	0.00284	CcSEcCtD
Halofantrine—Visual impairment—Conjugated Estrogens—osteoporosis	0.000779	0.00284	CcSEcCtD
Halofantrine—Malaise—Ethinyl Estradiol—osteoporosis	0.000778	0.00284	CcSEcCtD
Halofantrine—Anorexia—Calcitriol—osteoporosis	0.000778	0.00283	CcSEcCtD
Halofantrine—Back pain—Pamidronate—osteoporosis	0.000774	0.00282	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000767	0.0028	CcSEcCtD
Halofantrine—Dyspepsia—Estropipate—osteoporosis	0.000765	0.00279	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000759	0.00277	CcSEcCtD
Halofantrine—Dyspepsia—Alendronate—osteoporosis	0.000753	0.00275	CcSEcCtD
Halofantrine—Chills—Zoledronate—osteoporosis	0.000753	0.00274	CcSEcCtD
Halofantrine—Cough—Ethinyl Estradiol—osteoporosis	0.000753	0.00274	CcSEcCtD
Halofantrine—Arrhythmia—Zoledronate—osteoporosis	0.00075	0.00273	CcSEcCtD
Halofantrine—Fatigue—Estropipate—osteoporosis	0.000749	0.00273	CcSEcCtD
Halofantrine—Paraesthesia—Ibandronate—osteoporosis	0.000748	0.00273	CcSEcCtD
Halofantrine—Pollakiuria—Estradiol—osteoporosis	0.000746	0.00272	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000743	0.00271	CcSEcCtD
Halofantrine—Constipation—Estropipate—osteoporosis	0.000743	0.00271	CcSEcCtD
Halofantrine—Ill-defined disorder—Pamidronate—osteoporosis	0.000742	0.00271	CcSEcCtD
Halofantrine—Dyspepsia—Raloxifene—osteoporosis	0.000741	0.0027	CcSEcCtD
Halofantrine—Cough—Risedronate—osteoporosis	0.000734	0.00268	CcSEcCtD
Halofantrine—Dyspepsia—Ibandronate—osteoporosis	0.000733	0.00267	CcSEcCtD
Halofantrine—Constipation—Alendronate—osteoporosis	0.000732	0.00267	CcSEcCtD
Halofantrine—Discomfort—Ethinyl Estradiol—osteoporosis	0.000726	0.00265	CcSEcCtD
Halofantrine—Decreased appetite—Ibandronate—osteoporosis	0.000724	0.00264	CcSEcCtD
Halofantrine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000722	0.00263	CcSEcCtD
Halofantrine—Malaise—Pamidronate—osteoporosis	0.000721	0.00263	CcSEcCtD
Halofantrine—Fatigue—Ibandronate—osteoporosis	0.000718	0.00262	CcSEcCtD
Halofantrine—Myalgia—Risedronate—osteoporosis	0.000716	0.00261	CcSEcCtD
Halofantrine—Chest pain—Risedronate—osteoporosis	0.000716	0.00261	CcSEcCtD
Halofantrine—Arthralgia—Risedronate—osteoporosis	0.000716	0.00261	CcSEcCtD
Halofantrine—Constipation—Ibandronate—osteoporosis	0.000713	0.0026	CcSEcCtD
Halofantrine—Pruritus—Etidronic acid—osteoporosis	0.000711	0.00259	CcSEcCtD
Halofantrine—Gastrointestinal pain—Estropipate—osteoporosis	0.000711	0.00259	CcSEcCtD
Halofantrine—Decreased appetite—Calcitriol—osteoporosis	0.000709	0.00258	CcSEcCtD
Halofantrine—Back pain—Zoledronate—osteoporosis	0.000707	0.00258	CcSEcCtD
Halofantrine—Feeling abnormal—Alendronate—osteoporosis	0.000705	0.00257	CcSEcCtD
Halofantrine—Gastrointestinal pain—Alendronate—osteoporosis	0.0007	0.00255	CcSEcCtD
Halofantrine—Cough—Pamidronate—osteoporosis	0.000698	0.00254	CcSEcCtD
Halofantrine—Constipation—Calcitriol—osteoporosis	0.000698	0.00254	CcSEcCtD
Halofantrine—Convulsion—Pamidronate—osteoporosis	0.000693	0.00253	CcSEcCtD
Halofantrine—Urticaria—Estropipate—osteoporosis	0.00069	0.00252	CcSEcCtD
Halofantrine—Gastrointestinal pain—Raloxifene—osteoporosis	0.000688	0.00251	CcSEcCtD
Halofantrine—Diarrhoea—Etidronic acid—osteoporosis	0.000687	0.0025	CcSEcCtD
Halofantrine—Abdominal pain—Estropipate—osteoporosis	0.000687	0.0025	CcSEcCtD
Halofantrine—Feeling abnormal—Ibandronate—osteoporosis	0.000687	0.0025	CcSEcCtD
Halofantrine—Gastrointestinal pain—Ibandronate—osteoporosis	0.000681	0.00248	CcSEcCtD
Halofantrine—Myalgia—Pamidronate—osteoporosis	0.000681	0.00248	CcSEcCtD
Halofantrine—Arthralgia—Pamidronate—osteoporosis	0.000681	0.00248	CcSEcCtD
Halofantrine—Back pain—Conjugated Estrogens—osteoporosis	0.000681	0.00248	CcSEcCtD
Halofantrine—Urticaria—Alendronate—osteoporosis	0.00068	0.00248	CcSEcCtD
Halofantrine—Ill-defined disorder—Zoledronate—osteoporosis	0.000678	0.00247	CcSEcCtD
Halofantrine—Abdominal pain—Alendronate—osteoporosis	0.000677	0.00247	CcSEcCtD
Halofantrine—Discomfort—Pamidronate—osteoporosis	0.000673	0.00245	CcSEcCtD
Halofantrine—Gastrointestinal pain—Calcitriol—osteoporosis	0.000667	0.00243	CcSEcCtD
Halofantrine—Abdominal pain—Raloxifene—osteoporosis	0.000665	0.00243	CcSEcCtD
Halofantrine—Urticaria—Ibandronate—osteoporosis	0.000662	0.00241	CcSEcCtD
Halofantrine—Malaise—Zoledronate—osteoporosis	0.000659	0.0024	CcSEcCtD
Halofantrine—Abdominal pain—Ibandronate—osteoporosis	0.000659	0.0024	CcSEcCtD
Halofantrine—Confusional state—Pamidronate—osteoporosis	0.000658	0.0024	CcSEcCtD
Halofantrine—Anaphylactic shock—Pamidronate—osteoporosis	0.000653	0.00238	CcSEcCtD
Halofantrine—Urticaria—Calcitriol—osteoporosis	0.000648	0.00236	CcSEcCtD
Halofantrine—Palpitations—Zoledronate—osteoporosis	0.000646	0.00235	CcSEcCtD
Halofantrine—Abdominal pain—Calcitriol—osteoporosis	0.000645	0.00235	CcSEcCtD
Halofantrine—Vomiting—Etidronic acid—osteoporosis	0.000639	0.00233	CcSEcCtD
Halofantrine—Cough—Zoledronate—osteoporosis	0.000638	0.00232	CcSEcCtD
Halofantrine—Rash—Etidronic acid—osteoporosis	0.000633	0.00231	CcSEcCtD
Halofantrine—Convulsion—Zoledronate—osteoporosis	0.000633	0.00231	CcSEcCtD
Halofantrine—Dermatitis—Etidronic acid—osteoporosis	0.000633	0.00231	CcSEcCtD
Halofantrine—Headache—Etidronic acid—osteoporosis	0.000629	0.00229	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000626	0.00228	CcSEcCtD
Halofantrine—Asthenia—Estropipate—osteoporosis	0.000623	0.00227	CcSEcCtD
Halofantrine—Visual impairment—Estradiol—osteoporosis	0.000623	0.00227	CcSEcCtD
Halofantrine—Anorexia—Pamidronate—osteoporosis	0.000622	0.00227	CcSEcCtD
Halofantrine—Myalgia—Zoledronate—osteoporosis	0.000622	0.00227	CcSEcCtD
Halofantrine—Arthralgia—Zoledronate—osteoporosis	0.000622	0.00227	CcSEcCtD
Halofantrine—Chest pain—Zoledronate—osteoporosis	0.000622	0.00227	CcSEcCtD
Halofantrine—Palpitations—Conjugated Estrogens—osteoporosis	0.000622	0.00227	CcSEcCtD
Halofantrine—Paraesthesia—Risedronate—osteoporosis	0.000617	0.00225	CcSEcCtD
Halofantrine—Pruritus—Estropipate—osteoporosis	0.000615	0.00224	CcSEcCtD
Halofantrine—Discomfort—Zoledronate—osteoporosis	0.000615	0.00224	CcSEcCtD
Halofantrine—Asthenia—Alendronate—osteoporosis	0.000614	0.00224	CcSEcCtD
Halofantrine—Cough—Conjugated Estrogens—osteoporosis	0.000614	0.00224	CcSEcCtD
Halofantrine—Convulsion—Conjugated Estrogens—osteoporosis	0.00061	0.00222	CcSEcCtD
Halofantrine—Fatigue—Ethinyl Estradiol—osteoporosis	0.000607	0.00221	CcSEcCtD
Halofantrine—Pruritus—Alendronate—osteoporosis	0.000606	0.00221	CcSEcCtD
Halofantrine—Dyspepsia—Risedronate—osteoporosis	0.000604	0.0022	CcSEcCtD
Halofantrine—Tinnitus—Estradiol—osteoporosis	0.000603	0.0022	CcSEcCtD
Halofantrine—Constipation—Ethinyl Estradiol—osteoporosis	0.000602	0.0022	CcSEcCtD
Halofantrine—Confusional state—Zoledronate—osteoporosis	0.000601	0.00219	CcSEcCtD
Halofantrine—Chest pain—Conjugated Estrogens—osteoporosis	0.000599	0.00218	CcSEcCtD
Halofantrine—Arthralgia—Conjugated Estrogens—osteoporosis	0.000599	0.00218	CcSEcCtD
Halofantrine—Myalgia—Conjugated Estrogens—osteoporosis	0.000599	0.00218	CcSEcCtD
Halofantrine—Asthenia—Ibandronate—osteoporosis	0.000598	0.00218	CcSEcCtD
Halofantrine—Nausea—Etidronic acid—osteoporosis	0.000597	0.00217	CcSEcCtD
Halofantrine—Anaphylactic shock—Zoledronate—osteoporosis	0.000596	0.00217	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000595	0.00217	CcSEcCtD
Halofantrine—Diarrhoea—Estropipate—osteoporosis	0.000595	0.00217	CcSEcCtD
Halofantrine—Fatigue—Risedronate—osteoporosis	0.000592	0.00216	CcSEcCtD
Halofantrine—Pruritus—Ibandronate—osteoporosis	0.00059	0.00215	CcSEcCtD
Halofantrine—Constipation—Risedronate—osteoporosis	0.000587	0.00214	CcSEcCtD
Halofantrine—Paraesthesia—Pamidronate—osteoporosis	0.000586	0.00214	CcSEcCtD
Halofantrine—Diarrhoea—Alendronate—osteoporosis	0.000586	0.00213	CcSEcCtD
Halofantrine—Asthenia—Calcitriol—osteoporosis	0.000585	0.00213	CcSEcCtD
Halofantrine—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00058	0.00212	CcSEcCtD
Halofantrine—Chills—Estradiol—osteoporosis	0.00058	0.00212	CcSEcCtD
Halofantrine—Pruritus—Calcitriol—osteoporosis	0.000577	0.0021	CcSEcCtD
Halofantrine—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000576	0.0021	CcSEcCtD
Halofantrine—Diarrhoea—Raloxifene—osteoporosis	0.000576	0.0021	CcSEcCtD
Halofantrine—Dyspepsia—Pamidronate—osteoporosis	0.000575	0.00209	CcSEcCtD
Halofantrine—Dizziness—Estropipate—osteoporosis	0.000575	0.00209	CcSEcCtD
Halofantrine—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000574	0.00209	CcSEcCtD
Halofantrine—Diarrhoea—Ibandronate—osteoporosis	0.00057	0.00208	CcSEcCtD
Halofantrine—Anorexia—Zoledronate—osteoporosis	0.000568	0.00207	CcSEcCtD
Halofantrine—Decreased appetite—Pamidronate—osteoporosis	0.000567	0.00207	CcSEcCtD
Halofantrine—Dizziness—Alendronate—osteoporosis	0.000566	0.00206	CcSEcCtD
Halofantrine—Fatigue—Pamidronate—osteoporosis	0.000563	0.00205	CcSEcCtD
Halofantrine—Gastrointestinal pain—Risedronate—osteoporosis	0.000562	0.00205	CcSEcCtD
Halofantrine—Urticaria—Ethinyl Estradiol—osteoporosis	0.00056	0.00204	CcSEcCtD
Halofantrine—Constipation—Pamidronate—osteoporosis	0.000558	0.00203	CcSEcCtD
Halofantrine—Diarrhoea—Calcitriol—osteoporosis	0.000558	0.00203	CcSEcCtD
Halofantrine—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000557	0.00203	CcSEcCtD
Halofantrine—Dizziness—Raloxifene—osteoporosis	0.000557	0.00203	CcSEcCtD
Halofantrine—Vomiting—Estropipate—osteoporosis	0.000552	0.00201	CcSEcCtD
Halofantrine—Dizziness—Ibandronate—osteoporosis	0.000551	0.00201	CcSEcCtD
Halofantrine—Rash—Estropipate—osteoporosis	0.000548	0.002	CcSEcCtD
Halofantrine—Dermatitis—Estropipate—osteoporosis	0.000547	0.002	CcSEcCtD
Halofantrine—Anorexia—Conjugated Estrogens—osteoporosis	0.000547	0.00199	CcSEcCtD
Halofantrine—Urticaria—Risedronate—osteoporosis	0.000546	0.00199	CcSEcCtD
Halofantrine—Back pain—Estradiol—osteoporosis	0.000545	0.00199	CcSEcCtD
Halofantrine—Headache—Estropipate—osteoporosis	0.000544	0.00198	CcSEcCtD
Halofantrine—Vomiting—Alendronate—osteoporosis	0.000544	0.00198	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000543	0.00198	CcSEcCtD
Halofantrine—Abdominal pain—Risedronate—osteoporosis	0.000543	0.00198	CcSEcCtD
Halofantrine—Rash—Alendronate—osteoporosis	0.00054	0.00197	CcSEcCtD
Halofantrine—Dermatitis—Alendronate—osteoporosis	0.000539	0.00197	CcSEcCtD
Halofantrine—Feeling abnormal—Pamidronate—osteoporosis	0.000538	0.00196	CcSEcCtD
Halofantrine—Headache—Alendronate—osteoporosis	0.000536	0.00195	CcSEcCtD
Halofantrine—Paraesthesia—Zoledronate—osteoporosis	0.000535	0.00195	CcSEcCtD
Halofantrine—Vomiting—Raloxifene—osteoporosis	0.000535	0.00195	CcSEcCtD
Halofantrine—Gastrointestinal pain—Pamidronate—osteoporosis	0.000534	0.00195	CcSEcCtD
Halofantrine—Rash—Raloxifene—osteoporosis	0.000531	0.00193	CcSEcCtD
Halofantrine—Dermatitis—Raloxifene—osteoporosis	0.00053	0.00193	CcSEcCtD
Halofantrine—Vomiting—Ibandronate—osteoporosis	0.00053	0.00193	CcSEcCtD
Halofantrine—Headache—Raloxifene—osteoporosis	0.000527	0.00192	CcSEcCtD
Halofantrine—Rash—Ibandronate—osteoporosis	0.000525	0.00191	CcSEcCtD
Halofantrine—Dermatitis—Ibandronate—osteoporosis	0.000525	0.00191	CcSEcCtD
Halofantrine—Dyspepsia—Zoledronate—osteoporosis	0.000525	0.00191	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000523	0.00191	CcSEcCtD
Halofantrine—Ill-defined disorder—Estradiol—osteoporosis	0.000522	0.0019	CcSEcCtD
Halofantrine—Headache—Ibandronate—osteoporosis	0.000522	0.0019	CcSEcCtD
Halofantrine—Vomiting—Calcitriol—osteoporosis	0.000519	0.00189	CcSEcCtD
Halofantrine—Decreased appetite—Zoledronate—osteoporosis	0.000518	0.00189	CcSEcCtD
Halofantrine—Nausea—Estropipate—osteoporosis	0.000516	0.00188	CcSEcCtD
Halofantrine—Abdominal pain—Pamidronate—osteoporosis	0.000516	0.00188	CcSEcCtD
Halofantrine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000516	0.00188	CcSEcCtD
Halofantrine—Rash—Calcitriol—osteoporosis	0.000514	0.00187	CcSEcCtD
Halofantrine—Fatigue—Zoledronate—osteoporosis	0.000514	0.00187	CcSEcCtD
Halofantrine—Dermatitis—Calcitriol—osteoporosis	0.000514	0.00187	CcSEcCtD
Halofantrine—Headache—Calcitriol—osteoporosis	0.000511	0.00186	CcSEcCtD
Halofantrine—Constipation—Zoledronate—osteoporosis	0.00051	0.00186	CcSEcCtD
Halofantrine—Nausea—Alendronate—osteoporosis	0.000508	0.00185	CcSEcCtD
Halofantrine—Malaise—Estradiol—osteoporosis	0.000508	0.00185	CcSEcCtD
Halofantrine—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000505	0.00184	CcSEcCtD
Halofantrine—Asthenia—Ethinyl Estradiol—osteoporosis	0.000505	0.00184	CcSEcCtD
Halofantrine—Nausea—Raloxifene—osteoporosis	0.0005	0.00182	CcSEcCtD
Halofantrine—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000499	0.00182	CcSEcCtD
Halofantrine—Pruritus—Ethinyl Estradiol—osteoporosis	0.000498	0.00182	CcSEcCtD
Halofantrine—Palpitations—Estradiol—osteoporosis	0.000498	0.00181	CcSEcCtD
Halofantrine—Fatigue—Conjugated Estrogens—osteoporosis	0.000495	0.0018	CcSEcCtD
Halofantrine—Nausea—Ibandronate—osteoporosis	0.000495	0.0018	CcSEcCtD
Halofantrine—Asthenia—Risedronate—osteoporosis	0.000493	0.0018	CcSEcCtD
Halofantrine—Feeling abnormal—Zoledronate—osteoporosis	0.000491	0.00179	CcSEcCtD
Halofantrine—Cough—Estradiol—osteoporosis	0.000491	0.00179	CcSEcCtD
Halofantrine—Constipation—Conjugated Estrogens—osteoporosis	0.000491	0.00179	CcSEcCtD
Halofantrine—Gastrointestinal pain—Zoledronate—osteoporosis	0.000488	0.00178	CcSEcCtD
Halofantrine—Pruritus—Risedronate—osteoporosis	0.000486	0.00177	CcSEcCtD
Halofantrine—Nausea—Calcitriol—osteoporosis	0.000485	0.00177	CcSEcCtD
Halofantrine—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000482	0.00176	CcSEcCtD
Halofantrine—Arthralgia—Estradiol—osteoporosis	0.000479	0.00175	CcSEcCtD
Halofantrine—Myalgia—Estradiol—osteoporosis	0.000479	0.00175	CcSEcCtD
Halofantrine—Chest pain—Estradiol—osteoporosis	0.000479	0.00175	CcSEcCtD
Halofantrine—Urticaria—Zoledronate—osteoporosis	0.000474	0.00173	CcSEcCtD
Halofantrine—Discomfort—Estradiol—osteoporosis	0.000474	0.00173	CcSEcCtD
Halofantrine—Abdominal pain—Zoledronate—osteoporosis	0.000471	0.00172	CcSEcCtD
Halofantrine—Diarrhoea—Risedronate—osteoporosis	0.00047	0.00171	CcSEcCtD
Halofantrine—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.00047	0.00171	CcSEcCtD
Halofantrine—Asthenia—Pamidronate—osteoporosis	0.000468	0.00171	CcSEcCtD
Halofantrine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000466	0.0017	CcSEcCtD
Halofantrine—Confusional state—Estradiol—osteoporosis	0.000463	0.00169	CcSEcCtD
Halofantrine—Pruritus—Pamidronate—osteoporosis	0.000462	0.00168	CcSEcCtD
Halofantrine—Anaphylactic shock—Estradiol—osteoporosis	0.00046	0.00167	CcSEcCtD
Halofantrine—Urticaria—Conjugated Estrogens—osteoporosis	0.000456	0.00166	CcSEcCtD
Halofantrine—Dizziness—Risedronate—osteoporosis	0.000454	0.00166	CcSEcCtD
Halofantrine—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000454	0.00165	CcSEcCtD
Halofantrine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000448	0.00163	CcSEcCtD
Halofantrine—Diarrhoea—Pamidronate—osteoporosis	0.000447	0.00163	CcSEcCtD
Halofantrine—Rash—Ethinyl Estradiol—osteoporosis	0.000444	0.00162	CcSEcCtD
Halofantrine—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000444	0.00162	CcSEcCtD
Halofantrine—Headache—Ethinyl Estradiol—osteoporosis	0.000441	0.00161	CcSEcCtD
Halofantrine—Vomiting—Risedronate—osteoporosis	0.000437	0.00159	CcSEcCtD
Halofantrine—Rash—Risedronate—osteoporosis	0.000433	0.00158	CcSEcCtD
Halofantrine—Dermatitis—Risedronate—osteoporosis	0.000433	0.00158	CcSEcCtD
Halofantrine—Dizziness—Pamidronate—osteoporosis	0.000432	0.00157	CcSEcCtD
Halofantrine—Headache—Risedronate—osteoporosis	0.00043	0.00157	CcSEcCtD
Halofantrine—Asthenia—Zoledronate—osteoporosis	0.000428	0.00156	CcSEcCtD
Halofantrine—Pruritus—Zoledronate—osteoporosis	0.000422	0.00154	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000419	0.00153	CcSEcCtD
Halofantrine—Nausea—Ethinyl Estradiol—osteoporosis	0.000418	0.00152	CcSEcCtD
Halofantrine—Vomiting—Pamidronate—osteoporosis	0.000415	0.00151	CcSEcCtD
Halofantrine—Paraesthesia—Estradiol—osteoporosis	0.000413	0.0015	CcSEcCtD
Halofantrine—Asthenia—Conjugated Estrogens—osteoporosis	0.000412	0.0015	CcSEcCtD
Halofantrine—Rash—Pamidronate—osteoporosis	0.000412	0.0015	CcSEcCtD
Halofantrine—Dermatitis—Pamidronate—osteoporosis	0.000411	0.0015	CcSEcCtD
Halofantrine—Headache—Pamidronate—osteoporosis	0.000409	0.00149	CcSEcCtD
Halofantrine—Diarrhoea—Zoledronate—osteoporosis	0.000408	0.00149	CcSEcCtD
Halofantrine—Nausea—Risedronate—osteoporosis	0.000408	0.00149	CcSEcCtD
Halofantrine—Pruritus—Conjugated Estrogens—osteoporosis	0.000406	0.00148	CcSEcCtD
Halofantrine—Dyspepsia—Estradiol—osteoporosis	0.000405	0.00147	CcSEcCtD
Halofantrine—Decreased appetite—Estradiol—osteoporosis	0.000399	0.00146	CcSEcCtD
Halofantrine—Fatigue—Estradiol—osteoporosis	0.000396	0.00144	CcSEcCtD
Halofantrine—Dizziness—Zoledronate—osteoporosis	0.000394	0.00144	CcSEcCtD
Halofantrine—Constipation—Estradiol—osteoporosis	0.000393	0.00143	CcSEcCtD
Halofantrine—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000393	0.00143	CcSEcCtD
Halofantrine—Nausea—Pamidronate—osteoporosis	0.000388	0.00141	CcSEcCtD
Halofantrine—Dizziness—Conjugated Estrogens—osteoporosis	0.00038	0.00138	CcSEcCtD
Halofantrine—Vomiting—Zoledronate—osteoporosis	0.000379	0.00138	CcSEcCtD
Halofantrine—Feeling abnormal—Estradiol—osteoporosis	0.000379	0.00138	CcSEcCtD
Halofantrine—Rash—Zoledronate—osteoporosis	0.000376	0.00137	CcSEcCtD
Halofantrine—Gastrointestinal pain—Estradiol—osteoporosis	0.000376	0.00137	CcSEcCtD
Halofantrine—Dermatitis—Zoledronate—osteoporosis	0.000376	0.00137	CcSEcCtD
Halofantrine—Headache—Zoledronate—osteoporosis	0.000374	0.00136	CcSEcCtD
Halofantrine—Vomiting—Conjugated Estrogens—osteoporosis	0.000365	0.00133	CcSEcCtD
Halofantrine—Urticaria—Estradiol—osteoporosis	0.000365	0.00133	CcSEcCtD
Halofantrine—Abdominal pain—Estradiol—osteoporosis	0.000363	0.00132	CcSEcCtD
Halofantrine—Rash—Conjugated Estrogens—osteoporosis	0.000362	0.00132	CcSEcCtD
Halofantrine—Dermatitis—Conjugated Estrogens—osteoporosis	0.000362	0.00132	CcSEcCtD
Halofantrine—Headache—Conjugated Estrogens—osteoporosis	0.00036	0.00131	CcSEcCtD
Halofantrine—Nausea—Zoledronate—osteoporosis	0.000354	0.00129	CcSEcCtD
Halofantrine—Nausea—Conjugated Estrogens—osteoporosis	0.000341	0.00124	CcSEcCtD
Halofantrine—Asthenia—Estradiol—osteoporosis	0.00033	0.0012	CcSEcCtD
Halofantrine—Pruritus—Estradiol—osteoporosis	0.000325	0.00118	CcSEcCtD
Halofantrine—Diarrhoea—Estradiol—osteoporosis	0.000314	0.00115	CcSEcCtD
Halofantrine—Dizziness—Estradiol—osteoporosis	0.000304	0.00111	CcSEcCtD
Halofantrine—Vomiting—Estradiol—osteoporosis	0.000292	0.00106	CcSEcCtD
Halofantrine—Rash—Estradiol—osteoporosis	0.00029	0.00106	CcSEcCtD
Halofantrine—Dermatitis—Estradiol—osteoporosis	0.000289	0.00106	CcSEcCtD
Halofantrine—Headache—Estradiol—osteoporosis	0.000288	0.00105	CcSEcCtD
Halofantrine—Nausea—Estradiol—osteoporosis	0.000273	0.000995	CcSEcCtD
